2 results found
Efferon, a Startup Battlefield 200 participant, is combating pediatric sepsis with Efferon NEO, a blood purification device. It reduces organ failure and accelerates recovery in children by uniquely absorbing both endotoxins and cytokines. Already CE-marked and used in 30 countries, Efferon is now seeking FDA approval, aiming to save millions of young lives.
TechCrunch's Startup Battlefield is returning to Sydney, Australia, on August 19, 2026, in partnership with Stripe. Ten startups will pitch, with the winner securing automatic entry to TechCrunch Disrupt's Startup Battlefield 200 in San Francisco. This return follows the highly successful 2017 event, which launched companies like HealthMatch and FluroSat (now Regrow Agriculture) to raise over $85 million combined and foster a vibrant Australian tech ecosystem.
